Definitive Contract 75F40122C00023
Award Date
9/13/22
Potential Completion Date
9/15/25
Potential Value
$608K
Federal Agency
Food and Drug Administration
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
165
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Food and Drug Administration (FDA) awarded a $696,359 firm-fixed-price contract to Duke University's Office of Research Administration Division to conduct research and development activities in support of regulatory science and innovation. The contract, which does not have a set-aside designation, originated from a Broad Agency Announcement (BAA) that solicits advanced proposals across nine key areas to advance scientific knowledge in support of the FDA's mission to protect public...
This federal contract award, valued at $699,087.00, was issued by the Food and Drug Administration (FDA) to Duke University's Office of Research Administration Division. The contract is a definitive Firm Fixed Price contract with a period of performance through March 12, 2028. It was awarded under a Broad Agency Announcement (BAA) that solicits research and development proposals to support the FDA's regulatory science and innovation agenda. Duke University, a leading academic research...
This is a definitive contract awarded by the Food and Drug Administration (FDA) to Duke University in the amount of $1,046,733.02. The contract is for the "USE OF ELECTRONIC HEALTH RECORDS AS SOURCE DATA FOR CLINICAL RESEARCH" and has an ultimate completion date of December 28, 2020. The contract has a cost-no-fee pricing type and was not set aside for any socioeconomic program. Duke University, through its Office of Research Administration Division, is the prime contractor on this...
Duke University Office of Research Administration Division was awarded a $274,413 definitive contract by the Department of Health and Human Services Food and Drug Administration to conduct a study using electronic health records to identify and assess adverse events for biologic therapies. The contract aims to develop and validate methodological approaches under the agency's Broad Agency Announcement for the Advanced Research and Development of Regulatory Science, which seeks proposals to...
The University of North Carolina at Chapel Hill (UNC-CH), through its Office of Sponsored Research, was awarded a $4,521 firm fixed-price purchase order contract by the National Institute of Neurological Disorders and Stroke (NINDS), a component of the U.S. Department of Health and Human Services. The contract, which has a completion date of November 21, 2025, is for the provision of custom adeno-associated virus (AAV) preparations to be used in experiments related to spinal circuits and...
The federal contract award, valued at $565,343.09, was issued by the National Institute of Environmental Health Sciences (NIEHS) to the University of North Carolina at Chapel Hill (UNC-Chapel Hill) to provide gnotobiotic rodent services. This is a firm-fixed-price purchase order contract with a period of performance through September 15, 2023. UNC-Chapel Hill, through its Kenan Flagler Business School, has a history of providing educational services, training programs, and consulting to...
The Food and Drug Administration (FDA) awarded a $955,870 cost-no-fee delivery order contract to the State of North Carolina Department of Health & Human Services (NC DHHS) to obtain 2,310 units of UBS, 770 A&L's, non-inspection travel, and other direct costs to complete inspections from September 30, 2024 to September 29, 2025. This contract is part of a larger indefinite delivery vehicle (IDV) held by NC DHHS to conduct tobacco retail inspections and regulatory compliance services on...
The U.S. Food and Drug Administration (FDA) awarded a $296,477.00 definitive contract to the University of Florida (UF) Division of Sponsored Research for research related to "REAL-TIME RISK STRATIFICATION FOR HYPO- OR HYPERGLYCEMIA TO ENHANCE GLUCOSE MANAGEMENT OUTCOMES IN HOSPITALS." The contract, which is not set-aside, has a completion date of September 29, 2017. UF, a major research institution, has an extensive portfolio of federal contract and grant awards across various...
This is a $1,206,589.24 firm fixed-price contract awarded by the Food and Drug Administration (FDA) to Duke University's Office of Research Administration Division. The contract is for research and development to quantify patient priorities for clinical evidence on the impact of osseointegrated limb prostheses. This award was made under the FDA's Broad Agency Announcement for regulatory science and innovation research, with no set-aside designation. Duke University has previously received...
The U.S. Food and Drug Administration (FDA) awarded a $400,000.00 firm-fixed price contract to the Regents of the University of Michigan, Office of Research and Sponsored Projects (University of Michigan) to advance the science of in vitro, animal model, pharmacokinetic studies, and/or real-world evidence studies to facilitate drug development, including studies focused on antimicrobial resistance and drug development. This contract has a period of performance through March 31, 2026. The...